Drug intelligence / Profile preview

lidocaine + clonidine

Development stage
Unknown
Lead developer
University of Belgrade
Modality
Small Molecules
Administration
Parenteral
01

Overview

Lidocaine + clonidine is a local anesthetic combination formulation investigated for intraoral anesthesia, particularly in patients with type 2 diabetes mellitus (DMT2). It consists of 2% lidocaine, a voltage-gated sodium channel blocker, and 15 mcg/mL clonidine, an alpha-2 adrenergic receptor agonist. In this formulation, clonidine acts as a vasoconstrictor and analgesic adjuvant, serving as an alternative to epinephrine. Research conducted by the University of Belgrade suggests that this combination provides effective anesthesia for dental procedures like tooth extractions while maintaining stable cardiovascular parameters, making it a potentially safer option for patients with cardiovascular concerns or diabetes compared to traditional lidocaine-epinephrine mixtures.

Other names
L + Clidocaine plus clonidinelidocaine 2% + clonidine 15 mcg/mL
02

Targets

NaV (Voltage-gated sodium channels)ADRA2A (α2A)

Beyond the preview

Go deeper on lidocaine + clonidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + clonidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call